CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $38.36, moving -1.26% from the previous trading session.

Crispr Therapeutics AG (CRSP) stock saw a decline, ending the day at $38.85 which represents a decrease of $-0.84 or -2.12% from the prior close of $39.69. The stock opened at $39.06 and touched a low ...

Leerink Partners analyst Mani Foroohar has maintained their bullish stance on CRSP stock, giving a Buy rating on January 13.Stay Ahead of the ...

Brookstone Capital Management raised its holdings in Vanguard Mega Cap Growth ETF (NYSEARCA:MGK – Free Report) by 12.1% ...

VUG ETF invests in large-cap growth stocks. Check out 3 key reasons why the fund might not be a good choice from a portfolio ...

ETFs across various categories pulled in $17.7 billion in capital last week, with U.S. fixed-income ETFs leading the way.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

The Vanguard US Total Market Shares Index ETF (ASX: VTS) outperformed the Vanguard Australian Shares Index ETF (ASX: VAS) by ...

Citing positive developments in its development programs, analysts from a couple of investment banks think CRISPR Therapeutics(NASDAQ: CRSP) could more than double your money in the year ahead. Start ...

A smart beta exchange traded fund, the iShares Core High Dividend ETF (HDV) debuted on 03/29/2011, and offers broad exposure to the Style Box - Large Cap Value category of the market. What Are Smart ...

As market-capitalization-weighted index ETFs, both VOO and VTI naturally feature a high allocation to large-cap stocks. If ...

Princess Kate Middleton opened up about the side effects of chemo when she visited the Royal Marsden Hospital in London, ...